Department of Medicine
Tuesday, November 17, 2020
On Monday, Moderna became the second company to announce promising early results of its Phase 3 COVID-19 vaccine trial. The Pittsburgh site, led by Pitt’s Judy Martin, has seen more than 250 Pittsburghers roll up their sleeves to volunteer.
Tuesday, November 17, 2020
Monday, November 9, 2020
Four Pitt experts offer their thoughts on Pfizer’s announcement today of a vaccine that early data show is more than 90% effective in preventing COVID-19.
Friday, November 6, 2020
Wednesday, October 14, 2020
At Pitt, the MiGEL Lab and its robot liquid handler play a major role in processing surveillance testing samples. Learn how samples are pooled, tested and sequenced to help in the battle against COVID-19.
Thursday, September 10, 2020
Wednesday, September 9, 2020
The National Institutes of Health has selected Pitt to lead a trio of Phase 3 clinical trials involving COVID-19 patients that will explore the use of blood thinners in saving lives and improving care.
Thursday, August 13, 2020
Contact tracing has been underway at Pitt for months to help prevent the spread of COVID-19. To make it effective, the entire Pitt community is being asked to follow certain procedures when any of its members test positive or experience symptoms.